UTRF Startup Uses Audio Analytics to Predict Future Gastrointestinal Impairment

Gastrointestinal impairment (GII) is acute paralysis of the GI tract beginning two to seven days after major abdominal surgery. Around 25 percent of patients develop GII due to postoperative ileus (POI), a small bowel blockage or another postoperative complication. GII puts patients at risk and leads to readmission rates exceeding 20 percent following surgery. One… Read More

UTRF, UTHSC, and Anviron Partner to Commercialize Novel Treatment for Pancreatic Cancer

A Mission for Making Good Medicine The University of Tennessee Research Foundation (UTRF), the University of Tennessee Health Science Center (UTHSC), and biotech therapeutics startup Anviron recently announced a partnership to commercialize a novel treatment with promising efficacy against pancreatic cancer tumors. According to the Genetic and Rare Diseases Information Center, the total number of… Read More